165 related articles for article (PubMed ID: 18727667)
1. Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
Puri PK; Lountzis NI; Tyler W; Ferringer T
J Cutan Pathol; 2008 Dec; 35(12):1134-7. PubMed ID: 18727667
[TBL] [Abstract][Full Text] [Related]
2. Hydroxycholoroquine-induced hyperpigmentation.
Mir A; Boyd KP; Meehan SA; McLellan B
Dermatol Online J; 2013 Dec; 19(12):20723. PubMed ID: 24365014
[TBL] [Abstract][Full Text] [Related]
3. Hydroxychloroquine-induced hyperpigmentation.
Cho EB; Kim BC; Park EJ; Kwon IH; Cho HJ; Kim KH; Kim KJ
J Dermatol; 2012 Oct; 39(10):859-60. PubMed ID: 22671572
[No Abstract] [Full Text] [Related]
4. Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases.
Bahloul E; Jallouli M; Garbaa S; Marzouk S; Masmoudi A; Turki H; Bahloul Z
Lupus; 2017 Oct; 26(12):1304-1308. PubMed ID: 28355984
[TBL] [Abstract][Full Text] [Related]
5. Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study.
Jallouli M; Francès C; Piette JC; Huong du LT; Moguelet P; Factor C; Zahr N; Miyara M; Saadoun D; Mathian A; Haroche J; De Gennes C; Leroux G; Chapelon C; Wechsler B; Cacoub P; Amoura Z; Costedoat-Chalumeau N;
JAMA Dermatol; 2013 Aug; 149(8):935-40. PubMed ID: 23824340
[TBL] [Abstract][Full Text] [Related]
6. A case of hyperpigmentation induced by hydroxychloroquine and quinacrine in a patient with systemic lupus erythematosus and review of the literature.
Kwak D; Grimes PE
Int J Womens Dermatol; 2020 Sep; 6(4):268-271. PubMed ID: 33015284
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal melanonychia and subungual hemorrhage in a patient with systemic lupus erythematosus treated with hydroxychloroquine.
Zhang S; Liu X; Cai L; Zhang J; Zhou C
Lupus; 2019 Jan; 28(1):129-132. PubMed ID: 30428763
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine-induced hyperpigmentation.
Tracy CL; Blakey B; Parker G; Roebuck J
J Clin Rheumatol; 2013 Aug; 19(5):292. PubMed ID: 23884186
[No Abstract] [Full Text] [Related]
9. Woman in grey: hydroxychloroquine-induced hyperpigmentation.
Ivo R; Lopes CA; Reis R
BMJ Case Rep; 2018 Nov; 11(1):. PubMed ID: 30567137
[No Abstract] [Full Text] [Related]
10. Hydroxychloroquine-induced hyperpigmentation.
Kasper RS; Flueckiger B; Gobbi S; Lautenschlager S; Borelli S
J Dtsch Dermatol Ges; 2014 Feb; 12(2):158-61. PubMed ID: 24494645
[No Abstract] [Full Text] [Related]
11. Hydroxychloroquine-related hyperpigmentation.
Muller R; Jarrot PA; Kaplanski G
Rheumatology (Oxford); 2022 Feb; 61(2):873. PubMed ID: 33871581
[No Abstract] [Full Text] [Related]
12. Hydroxychloroquine-induced hyperpigmentation of the skin and bull's-eye maculopathy in rheumatic patients: a case report and literature review.
Peng JP; Yang XY; Luo F; Yuan XM; Xiong H; Ma WK; Yao XM
Front Immunol; 2024; 15():1383343. PubMed ID: 38660312
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous hyperpigmentation during therapy with hydroxychloroquine.
Amichai B; Gat A; Grunwald MH
J Clin Rheumatol; 2007 Apr; 13(2):113. PubMed ID: 17414546
[No Abstract] [Full Text] [Related]
14. Clinical images: Hydroxychloroquine-associated mucocutaneous hyperpigmentation.
True DG; Bryant LR; Harris MD; Bernert RA
Arthritis Rheum; 2002 Jun; 46(6):1698. PubMed ID: 12115210
[No Abstract] [Full Text] [Related]
15. Hyperpigmentation of the skin due to hydroxychloroquine.
Rood MJ; Vermeer MH; Huizinga TW
Scand J Rheumatol; 2008; 37(2):158. PubMed ID: 18415776
[No Abstract] [Full Text] [Related]
16. Hydroxychloroquine safety: A meta-analysis of randomized controlled trials.
Eljaaly K; Alireza KH; Alshehri S; Al-Tawfiq JA
Travel Med Infect Dis; 2020; 36():101812. PubMed ID: 32645478
[TBL] [Abstract][Full Text] [Related]
17. Drug-associated hyperpigmentation of the oral mucosa: report of four cases.
Tosios KI; Kalogirou EM; Sklavounou A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Mar; 125(3):e54-e66. PubMed ID: 29287748
[TBL] [Abstract][Full Text] [Related]
18. Oral manifestations associated with antimalarial therapy in patients with systemic lupus erythematosus.
Chacón-Dulcey V; López-Labady J; Villarroel-Dorrego M; Frías J; Tirado W; González N; Pérez Alfonzo R
Lupus; 2020 Jun; 29(7):761-766. PubMed ID: 32362181
[TBL] [Abstract][Full Text] [Related]
19. The Pharmacological Mechanisms and Therapeutic Activities of Hydroxychloroquine in Rheumatic and Related Diseases.
Hu C; Lu L; Wan JP; Wen C
Curr Med Chem; 2017; 24(20):2241-2249. PubMed ID: 28302011
[TBL] [Abstract][Full Text] [Related]
20. Statins in rheumatoid arthritis--two birds with one stone?
Klareskog L; Hamsten A
Lancet; 2004 Jun; 363(9426):2011-2. PubMed ID: 15207947
[No Abstract] [Full Text] [Related]
[Next] [New Search]
